Chemically disordered face centered cubic (fcc) FePt nanoparticles (NPs) show the controlled release of Fe in low pH solution. The released Fe catalyzes H(2)O(2) decomposition into reactive oxygen species within cells, causing fast oxidation and deterioration of cellular membranes. Functionalized with luteinizing hormone-releasing hormone (LHRH) peptide via phospholipid, the fcc-FePt NPs can bind preferentially to the human ovarian cancer cell line (A2780) that overexpresses LHRH receptors and exhibit high toxicity to these tumor cells. In contrast, the fcc-FePt NPs pre-etched in the low pH (4.8) buffer solution show nonappreciable cytotoxicity. The work demonstrates that fcc-FePt NPs may function as a new type of agent for controlled cancer therapy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791709 | PMC |
http://dx.doi.org/10.1021/ja905938a | DOI Listing |
Nanoscale
August 2022
Key Laboratory of Anisotropy and Texture of Materials (Ministry of Education), School of Materials Science and Engineering, Northeastern University, Shenyang 110819, China.
A facile strategy to operate interfaces when synthesizing L1-FePt@Bi-rich nanoparticles (NPs) has been proposed. Two interfaces are indispensable to obtain the high ordering L1-FePt structure. One is the mismatched interfaces between the initial γ-PtBi nuclei and the disordered fcc-FePt phase.
View Article and Find Full Text PDFNanotechnology
July 2019
School of Materials Science and Engineering, Qingdao University, Qingdao 266071, People's Republic of China. Key Laboratory of Functional Nanomaterials and Technology in Universities of Shandong, Linyi University, Linyi 276000, People's Republic of China.
Circulating tumor cells (CTCs) are a type of rare cell that are firstly shed from solid tumors and then exist in the bloodstream. The effective capture and separation of CTCs has significant meaning in cancer diagnosis and prognosis. In this study, novel FeO-FePt magnetic nanocomposites (FeO-FePt MNCs) were constructed by integrating face centered cubic (fcc) FePt nanoparticles (NPs) onto the surface of the FeO@SiO core.
View Article and Find Full Text PDFBioconjug Chem
February 2017
Radiology Departments, Qilu Hospital of Shandong University, Jinan, Shandong 250000, China.
Multifunctional nanotheranostic agents have been highly commended due to the application to image-guided cancer therapy. Herein, based on the chemically disordered face centered cubic (fcc) FePt nanoparticles (NPs) and graphene oxide (GO), we develop a pH-responsive FePt-based multifunctional theranostic agent for potential in vivo and in vitro dual modal MRI/CT imaging and in situ cancer inhibition. The fcc-FePt will release highly active Fe ions due to the low pH in tumor cells, which would catalyze HO decomposition into reactive oxygen species (ROS) within the cells and further induce cancer cell apoptosis.
View Article and Find Full Text PDFJ Nanosci Nanotechnol
January 2010
Division of Materials and Manufacturing Science, Graduate School of Engineering, Osaka University, 2-1 Yamada-oka, Suita, Osaka 565-0871, Japan.
A direct synthetic route of FePt nanoparticles (NPs) has been developed. Reduction of platinum acethylacetonate (Pt(acac)2) and thermal decomposition of iron carbonyl (Fe(CO)5) in the presence of L-cysteine produced fcc FePt NPs with a mean diameter of 2.9 nm.
View Article and Find Full Text PDFJ Am Chem Soc
April 2010
Department of Chemistry, Brown University, Providence, Rhode Island 02912, USA.
We report the structure-controlled synthesis of FePt/MgO NPs and their catalysis for oxygen reduction reaction (ORR) in 0.5 M H(2)SO(4) solution. The synthesis yields fcc-FePt/MgO and fct-FePt/MgO NPs with the MgO coating being readily removed for catalytic studies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!